GLUD1 and hepatocellular carcinoma: About 129 metabolites were identified with significant differences (VIP ≥ 1, p < 0.05), among which 49 metabolites were down-regulated and 80 metabolites were up-regulated in GLUD1 overexpressing HCC cells (Fig. 4B and C, Table S1).